The Osteoporosis Prevention and Arterial effects of tiboLone (OPAL) study: design and baseline characteristics

Author： Bots M.L.   Evans G.W.   Riley W.   Meijer R.   McBride K.H.   Paskett E.D.   Helmond F.A.   Grobbee D.E.   for the OPAL Investigators  

Publisher： Elsevier

ISSN： 0197-2456

Source： Controlled Clinical Trials, Vol.24, Iss.6, 2003-12, pp. : 752-775

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics

By The BENEDICT Group  

Controlled Clinical Trials, Vol. 24, Iss. 4, 2003-08 ,pp. : 442-461

Elsevier

Access to resources Recommend Favorite

Osteoporosis-its causes and prevention: an update

By Turner P. A.  

Physiotherapy Theory and Practice, Vol. 16, Iss. 3, 2000-09 ,pp. : 135-149

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of Calcitonin in the Prevention and Treatment of Osteoporosis

By Reginster Y.   Reginster J-Y.  

BioDrugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 295-300

Adis International

Access to resources Recommend Favorite

Baseline

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 42-42

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Baseline

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 32-32

Nova Science Publishers, Inc.

Access to resources Recommend Favorite